Isabelle B. Lefebvre

Isabelle B. Lefebvre is an accomplished professional in regulatory affairs and quality, currently serving as Chief Regulatory Officer and SVP of Regulatory Affairs & Quality at EyePoint Pharmaceuticals since March 2022. With extensive experience in leading regulatory strategies for pharmaceutical products, Isabelle held significant roles including Vice President at Hengrui Medicine USA and Bausch Health Companies Inc., where responsibilities encompassed development, registration, and post-approval management for a variety of therapeutic areas. Previous positions at Valeant Pharmaceuticals and Lundbeck Inc. involved directing regulatory activities and strategies that ensured compliance and the successful approval of drug products. Isabelle's educational background includes a Master's in Regulatory Affairs from Northeastern University and an Executive Development Course from Northwestern University's Kellogg School of Management, complemented by a solid foundation in biochemistry from Université de Montréal.